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ABSTRACT 
The increasing demand and hampered use of primary human hepatocytes for research purposes have urged scien-
tists to search for alternative cell sources, such as immortalized hepatic cell lines. The aim of this study was to 
develop a human hepatic cell line using the combined overexpression of TERT and the cell cycle regulators cy-
clin D1 and mutant isoform CDK4R24C. Following transduction of adult human primary hepatocytes with the 
selected immortalization genes, cell growth was triggered and a cell line was established. When cultured under 
appropriate conditions, the cell line expressed several hepatocytic markers and liver-enriched transcription fac-
tors at the transcriptional and/or translational level, secreted liver-specific proteins and showed glycogen deposi-
tion. These results suggest that the immortalization strategy applied to primary human hepatocytes could gener-
ate a novel hepatic cell line that seems to retain some key hepatic characteristics.  
 
Keywords: human hepatocytes, immortalization, hepatic cell line 
 
 
Abbreviations: A1AT, alpha-1-antitrypsin; ACTB, beta actin; AFP, alpha-fetoprotein; ALB, albumin; B2M, be-
ta-2 microglobulin; BSA, bovine serum albumin; BSEP, bile salt export pump; C/EBPα , CCAAT/enhancer 
binding protein α; CDK4, cyclin dependent kinase 4; CK, cytokeratin; Cy, cyanine; CYP450, cytochrome P450 
monooxygenase; cDNA, complementary deoxyribonucleic acid; DIHH-ET cells, differentiated IHH-ET cells; 
ELISA, enzyme-linked immunosorbent assay; FITC, fluorescein; FSC, forward scatter; GAPDH, glyceralde-
hyde-3-phosphate dehydrogenase; G6PD, glucose-6-phosphate dehydrogenase; GGT1, gamma-glutamyl-
transferase 1; HEK293t, Human Embryonic Kidney 293t; HH, human hepatocytes; HNF, hepatocyte nuclear fac-
tor; HPRT1, hypoxanthine ribosyltransferase 1; IHH-ET cells, immortalized human hepatocytes; (m)RNA, 
(messenger)ribonucleic acid; MRP, multidrug resistance-associated protein; NC, negative control; NTCP, sodi-
um-dependent taurocholate cotransporting polypeptide; PAS, Periodic acid Schiff; PBS, phosphate buffered sa-
line; PC, positive control; PDT, population doubling time; PerCP, Peridinin chlorophyll protein complex; RIPA, 
radioimmunoprecipitation assay; R-PE, R-phycoerythrin; RT-qPCR, real-time quantitative polymerase chain re-
action; SSC, side scatter; TBS-T, Tris-buffered saline solution; TERT, telomerase reverse transcriptase; UBC, 
ubiquitin C; WB, western blot. 
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INTRODUCTION 
Pharmaco-toxicological research of new 
chemical and biological entities is usually 
performed in experimental animals. Because 
of scientific, ethical and economic reasons, 
however, animal use has been heavily criti-
cized and therefore became less acceptable. 
Hence, increasing attention is currently fo-
cused on the establishment and use of appro-
priate in vitro models, especially liver-based 
testing systems (EFPIA, 2012). Among the 
in vitro liver models available today, primary 
human hepatocyte cultures are generally 
considered as the gold standard. Neverthe-
less, the overall shortage of human hepato-
cytes for research purposes, the restricted 
cultivation time due to the occurrence of de-
differentiation and the lack of cell dividing 
potential impede their general use. Immortal-
ization of primary human hepatocytes, yield-
ing a virtually unlimited cell supply and a 
fully functional hepatic cell line, could offer 
a solution (Deurholt et al., 2009; Reid et al., 
2009). Over the years, a plethora of immor-
talized human hepatic cell lines has been in-
troduced. A frequently applied strategy for 
the immortalization of adult human hepato-
cytes is based on the use of viral oncogenes, 
whether or not in combination with telomer-
ase reverse transcriptase (TERT) protein. 
However, by using this methodology most 
hepatic cell lines often largely lack in vivo-
like hepatic functionality (Ramboer et al., 
2014).  
In the present study, a novel immortaliza-
tion strategy for hepatocytes is proposed. It 
relies on the observation that the p16-
regulated premature growth arrest observed 
in several epithelial cells might be partially 
involved in the limited proliferation capacity 
of adult hepatocytes in vitro (Auer et al., 
1998; Tombes et al., 1998; Ramirez et al., 
2001, 2003; Ohtani et al., 2004; Harashima 
et al., 2013; Ramboer et al., 2014). This in-
novative immortalization technique has been 
successfully applied to human myogenic 
cells and uses a combination of 3 genes, 
namely cyclin D1, a mutant isoform of cy-
clin dependent kinase 4 (CDK4R24C) and 
TERT, in order to obtain cellular immortali-
zation through abolishment of p16 function 
and reactivation of telomerase (Shiomi et al., 
2011). Here, we explore whether this strate-
gy is also applicable to primary human 
hepatocytes.  
 
MATERIAL AND METHODS 
Vector production and characterization  
Plasmids used for the production of the 
lentiviral vectors were kindly provided by 
Dr. T Kiyono (Shiomi et al., 2011). The 
CMV-CDK4R24C, CMV-cyclin D1 and 
CMV-TERT lentiviral vectors were trans-
fected with packaging vectors by a calcium 
phosphate transfection in human embryonic 
kidney 293t (HEK293t) cells. Supernatants, 
containing a viral construct, were collected 
and filtered 48 hours after transfection. The 
viral suspensions were stored at -80 °C. For 
characterization of the produced vectors, 
HEK293t cells were transduced with every 
single vector separately and samples for real 
time quantitative polymerase chain reaction 
(RT-qPCR) and western blot (WB) analyses 
were taken approximately 2 weeks after cul-
tivation. 
 
Human hepatocyte cultivation and  
transduction 
Cryopreserved human hepatocytes (do-
nor No.HH223, BD bioscience, Belgium) 
were used in these experiments. Thawing 
was performed according to the manufactur-
er’s instructions using the One step purifica-
tion kit (BD Bioscience, Belgium). Human 
hepatocytes were seeded on a 24-well plastic 
surface at a density of approximately 2.105 
cells/well in Williams’ medium E (Invitro-
gen, Belgium) supplemented with 7 ng/ml 
glucagon, 292 mg/ml L-glutamine, antibiot-
ics (7.33 I.E./ml sodium benzyl penicillin, 50 
µg/ml kanamycin monosulphate, 10 µg/ml 
sodium ampicillin, 50 µg/ml streptomycin 
sulphate) and 10 % v/v foetal bovine serum 
(Gibco, Belgium). Cell culture plates were 
placed in an incubator (37 °C, 5 % v/v CO2) 
and after approximately 16 hours, cell cul-
ture medium was removed and replaced by 
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serum-rich medium supplemented with 25 
µg/ml hydrocortisone sodium hemisuccinate 
and 0.5 µg/ml insulin (’growth cell culture 
medium’). On day 2 of cultivation, the cells 
were simultaneously exposed for approxi-
mately 16 hours to CMV-CDK4R24C, 
CMV-cyclin D1 and CMV-TERT lentiviral 
suspensions. All hepatocyte cultures were 
maintained in an incubator (37 °C, 5 % v/v 
CO2) and cell culture medium was replaced 
daily.  
 
Hepatic cell line cultivation and  
differentiation 
At 80 to 90 % confluence, cells were 
washed with phosphate-buffered saline 
(PBS) and trypisinized with TrypLE™ (Life 
technologies, Belgium). Cell counting was 
performed using a TC10™ automated cell 
counter (Bio-Rad, Belgium). Cells were ei-
ther subcultured on a plastic surface in 
growth cell culture medium at a cell density 
of approximately 5500 cells/cm2 or frozen in 
growth cell culture medium supplemented 
with 10 % v/v dimethylsulfoxide. For differ-
entiation purposes, cells were grown until 
nearly confluent in growth culture medium 
(‘IHH-ET cells’) and cultured for 2 more 
weeks in serum-free culture medium, com-
posed of Williams’ medium E supplemented 
with 7 ng/ml glucagon, 292 mg/ml L-
glutamine, antibiotics (7.33 I.E./ml sodium 
benzyl penicillin, 50 µg/ml kanamycin 
monosulphate, 10 µg/ml sodium ampicillin, 
50 µg/ml streptomycin sulphate), 25 µg/ml 
hydrocortisone sodium hemisuccinate and 
0.5 µg/ml insulin (’differentiation cell cul-
ture medium’). All hepatocyte cultures were 
maintained in an incubator (37 °C, 5 % v/v 
CO2) and cell culture medium was replaced 
every 2 days. 
 
Real-time quantitative polymerase chain 
reaction analysis 
Cells were washed with cold PBS and 
harvested by trypsinization. Total cellular ri-
bonucleic acid (RNA) extraction, and com-
plementary deoxyribonucleic acid (cDNA) 
production and cDNA purification were car-
ried out as explained elsewhere (De Kock et 
al., 2012). The RT-qPCR reaction mix and 
RT-qPCR conditions, using the StepOnePlus 
system (Applied Biosystems, Belgium), were 
established according to the manufacturer’s 
instructions (Applied Biosystems, Belgium). 
Gene mixes were purchased from Applied 
Biosystems (Table 1). Selection of reliable 
housekeeping genes for normalization of the 
RT-qPCR data was done using geNorm 
within the qbase+ software (Biogazelle, Bel-
gium). The results were processed with the 
qbase+ software (Biogazelle, Belgium). 
 
Western blot analysis 
Cells were washed with cold PBS and 
harvested by trypsinization. Total cellular 
protein extraction was carried out using the 
radio-immunoprecipitation assay (RIPA) ly-
sis buffer completed with Halt Protease In-
hibitor Cocktail (Thermo Scientific Pierce, 
Belgium) and total cellular protein quantifi-
cation was performed with the bichincho-
ninic acid protein kit and bovine serum al-
bumin (BSA) as standard, both according to 
the manufacturer’s instructions (Thermo 
Scientific Pierce, Belgium). Except for 
TERT analysis, proteins (25 μg) were heat-
ed, fractionated on sodium dodecyl sulphate 
polyacrylamide 7.5 % or 10 % w/v gel and 
blotted afterwards onto nitrocellulose mem-
branes (Amersham, United Kingdom). To 
control the efficiency of the blotting as well 
as equal loading of the proteins on the gel, 
reversible protein staining was performed us-
ing a 0.1 % w/v Ponceau S solution. For 
TERT analysis, the subsequent steps were 
performed using the Supersignal Western 
Blot Enhancer kit (Pierce, Belgium). Mem-
branes were blocked with 5 % w/v non-fatty 
milk in Tris-buffered saline solution (TBS-
T). Membranes were incubated overnight at 
4 °C with primary antibodies (Table 2) fol-
lowed by incubation for 1 hour at room tem-
perature with a horseradish peroxidase-
conjugated secondary antibody (Dako, Den-
mark). Excess of antibody was removed by 
washing the membranes several times with 
TBS-T. Detection of the proteins was carried 
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out by means of an enhanced chemilumines-
cence Western blotting system (Pierce 
Thermo Scientific, Belgium). Where appli-
cable, blots were further incubated with a 
primary antibody directed against a reliable 
housekeeping gene (Table 2).  
 
Population doubling time  
For doubling time assays, cells were 
plated in 6-well plates and cultured for 5 
days in growth cell culture medium. At spe-
cific time points, namely after 6, 24, 48, 72, 
96, 120 hours of cultivation, cells of 3 wells 
were washed once with 1.4 ml/well PBS, 
trypsinized with 1 ml/well TrypLE™ and re-
suspended in 0.250 ml growth cell culture 
medium. Cell numbers were determined by 
means of a TC10™ automated cell counter 
(Bio-Rad, Belgium). The population dou-
bling time was calculated using the equation 
(t2-t1)/3.32 x (log n2- log n1), based on the 
linear part of the curve.  
 
 
Table 1: Gene expression assays used for real time quantitative polymerase chain reaction analysis 
Gene Assay-On-Demand ID 
Amplicon length 
(bp) 
A1AT (SERPINA1) Hs01097800_m1 126 
ACTB Hs99999903_m1 171 
AFP Hs01040597_m1 62 
ALB Hs00910225_m1 137 
B2M Hs99999907_m1 75 
BSEP (ABCB11) Hs00184824_m1 63 
C/EBPα Hs00269972_s1 77 
CDK4 Hs00175935_m1 65 
CK18 Hs02827483_g1 64 
CK19 Hs00761767_s1 116 
CK7 Hs00559840_m1 95 
CK8 Hs01595539_g1 164 
Cyclin D1 (CCND1) Hs00765553_m1 57 
CYP1A2 Hs00167927_m1 67 
CYP3A4 Hs00604506_m1 119 
CYP3A7 Hs00426361_m1 119 
G6PD Hs00166169_m1 94 
GAPDH Hs99999905_m1 122 
GATA4 Hs00171403_m1 68 
GGT1 Hs00980756_m1 60 
HNF1α Hs00167041_m1 96 
HNF3β Hs00232764_m1 66 
HNF4α Hs00230853_m1 49 
HPRT1 Hs99999909_m1 100 
MRP1 (ABCC1) Hs01561502_m1 69 
MRP2 (ABCC2) Hs00166123_m1 75 
NTCP (SLC10A1) Hs00161820_m1 68 
OATP1B1 (SLCO1B1) Hs00272374_m1 77 
TERT Hs00972656_m1 79 
THY1 Hs00264235_s1 99 
UBC Hs00824723_m1 71 
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Table 2: Primary antibodies used for western blot analysis 
Antigen Supplier Reference Species Type Dilution % Seperat-ing gel 
A1AT Abcam ab49088 Rabbit polyclonal 1/1000 10 
CDK4 Santa Cruz sc-260 Rabbit polyclonal 1/1000 10 
CK18 Abcam ab32118 Rabbit monoclonal 1/10000 10 
CK19 Abcam ab76539 Rabbit monoclonal 1/10000 10 
CK7 Abcam ab68459 Rabbit monoclonal 1/5000 10 
Cyclin D1 Santa Cruz sc-753 Rabbit polyclonal 1/1000 10 
GAPDH Abcam ab8245 Mouse monoclonal 1/20000 / 
HNF1α Santa Cruz sc-10791 Rabbit polyclonal 1/1000 10 
HNF4α Santa Cruz sc-8987 Rabbit polyclonal 1/1000 10 
TERT Santa Cruz sc-7212 Rabbit polyclonal 1/1000 7.5 
 
 
Flow cytometry 
To determine the expression profile of 
the 3 immortalization genes in the whole cell 
population, flow cytometry analyses were 
performed. IHH-ET cells were harvested, 
fixed with 4 % w/v paraformaldehyde solu-
tion and permeabilized using a 0.1 % v/v 
PBS-Triton solution. After washing twice 
with PBS supplemented with 1 % w/v BSA, 
cells were incubated for 1 hour at room tem-
perature with fluorescence labelled primary 
antibodies, namely CDK4-FITC, cyclin D1-
R-PE and TERT-PerCP-Cy5.5. Following a 
final washing step, cells were resuspended in 
PBS, counterstained with Hoechst and ana-
lysed using the Attune® Acoustic Focusing 
Cytometer (Life Technologies, Belgium). 
FITC, R-PE, PerCP-CY5.5 and Hoechst-
positive events were recorded and the appro-
priate compensation settings were applied. 
Labelling of the primary antibodies, CDK4, 
cyclin D1 and TERT (Santa Cruz,USA), was 
carried out using the antibody concentration 
kit and conjugation kits (Abcam, UK). 
 
Light microscopy  
The morphology of the cell cultures was 
monitored every 2 days by inverse light mi-
croscopy (Nikon, Belgium). Images were 
taken at 100x magnification. 
 
Enzyme-linked immunosorbent assay 
Cells were cultured in a 6-well plate and, 
following cultivation, the secretion of albu-
min (ALB) (AssayPro, USA) and alpha-1-
antitrypsin (A1AT) (Abcam, UK) in the cell 
culture medium was quantified by enzyme-
linked immunosorbent assay (ELISA) ac-
cording to the manufacturer’s instructions. 
For normalization of secretion values, the to-
tal protein content from each well was de-
termined according to the Bradford method 
(Bradford, 1976) using BSA as a standard. 
 
Glycogen storage 
To demonstrate the presence of glycogen 
deposition, a Periodic acid Schiff (PAS) 
staining was performed. Briefly, cells were 
fixed with a 4 % w/v paraformaldehyde solu-
tion, washed 3 times with PBS and incubated 
with 100 mM glycin. After 3 additional 
washing steps, the cells were stained for 10 
minutes with periodic acid, washed 3 times 
with PBS and then stained for 15 minutes 
with Schiff’s reagent. Finally, cells were 
successively washed with PBS, counter-
stained with hematoxylin solution, rinsed 
with water and dried to air prior to micro-
scopic examination and imaging at 200x 
magnification (Nikon, Belgium). To confirm 
glycogen accumulation and serving as a neg-
ative control, a 0.2 % w/v diastase digestion 
was completed before performing the PAS 
staining.  
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Statistical analysis 
Results were evaluated using a 2-tailed 
unpaired Student’s t-test with level of signif-
icance p ≤ 0.05. Data are expressed as mean 
± standard deviation of cells originating from 
different cultivations (n) or from one and the 
same cultivation (N). 
 
RESULTS 
Efficiency of the lentiviral vector constructs 
Lentiviral vectors containing the coding 
sequences for cyclin D1, CDK4R24C and 
TERT were constructed. To test the efficien-
cy of these vectors, HEK293t cells were 
transduced with every construct separately. 
As such, 4 different cell lines, namely  
(i) cyclin D1-transduced HEK293t cells,  
(ii) CDK4R24C-transduced HEK293t cells,  
(iii) TERT-transduced HEK293t cells and 
(iv) non-transduced HEK293 cells (’control’) 
were generated. The expression of the im-
mortalization genes was determined at the 
transcriptional and translational level. Both 
mRNA and protein quantities of cyclin D1, 
CDK4 and TERT appear to be upregulated 
in the respective transduced HEK293t cell 
line compared to the non-transduced 
HEK293t cells (Figure 1). 
 
Development of a human hepatic cell line 
Cryopreserved adult human hepatocytes 
were transduced with a combination of the 3 
verified lentiviral vectors. Cell growth was 
observed within 2 weeks. The resulting cell 
line has been cultivated for over 15 passages 
and possesses a population doubling time 
(PDT) of approximately 30 hours (Figure 2).  
RT-qPCR (Figure 3A) and WB (Figure 
3B) analyses revealed apparently increased 
levels of cyclin D1, CDK4 and TERT in the 
transduced cell line compared to the non-
transduced cells.  
To determine the expression profile of 
the 3 immortalization genes in the whole cell 
line population, flow cytometry analyses 
were carried out. It was found that CDK4, 
TERT and cyclin D1 were expressed by 
99.3 %, 96.6 % and 82.9 % of the cells, re-
spectively (Figure 4A). Combination of the 
expression profiles of cyclin D1 and TERT 
indicates that at least 80.4 % of the cells pos-
sess the 3 immortalization genes (Figure 
4B).  
 
Figure 1: mRNA and protein expression levels of 
the immortalization genes in transduced 
HEK293t cells 
HEK293t cells were separately transduced with 
lentiviral vectors, coding for cyclin D1, 
CDK4R24C, and TERT. Samples were taken 
approximately 2 weeks after transduction (n=1, 
N=1). A) Samples were subjected to RT-qPCR 
analysis, using ACTB and GAPDH as a combi-
nation of reference genes for normalization. The 
results were processed with the qbase+ software 
and relative mRNA expression levels were nor-
malized against the geometric mean of both ref-
erence genes and scaled to the values of non-
transduced HEK293t cells. Each sample was 
analyzed in duplicate and results are expressed 
as mean in logarithmic scale. B) Samples (25 µg 
protein) were subjected to WB analysis. Each 
sample was analyzed in duplicate. Primary anti-
bodies against cyclin D1, CDK4 or TERT were 
used followed by an appropriate secondary anti-
body. The protein expression of the endogenous 
control, GAPDH, is used as control for equal 
loading. (ACTB, beta actin; CDK4, cyclin-
dependent kinase 4; GAPDH, glyceraldehyde 3-
phosphate hydrogenase; HEK293t, human em-
bryonic kidney 293t; mRNA, messenger ribonu-
cleic acid; RT-qPCR, real time quantitative poly-
merase chain reaction; TERT, telomerase re-
verse transcriptase; WB, western blot) 
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Figure 2: Population doublings of the cell line  
Cells were plated in 6-well plates and cultured for 
5 days in growth cell culture medium. At specific 
time points, specifically after 6, 24, 48, 72, 96, 
120 hours of cultivation, cell numbers from 3 dif-
ferent wells (N=3) were determined. Results are 
expressed as mean + standard deviation of 2 dif-
ferent cultivations (n=2). Boxed area indicates 
linear part of the curve used for calculation of 
PDT. (PDT, population doubling time) 
 
Morphological and functional characteriza-
tion of a human hepatic cell line 
To characterize the newly developed cell 
line, the morphology of the cells was moni-
tored during cultivation. As depicted in Fig-
ure 5, the cells do not possess the typical cu-
boidal morphology of human hepatocytes. 
Structural heterogeneity can be observed 
within the transduced cell population. When 
the cells were cultured for 2 more weeks in 
differentiation cell culture medium to trigger 
differentiation, cellular overgrowth occurred 
and cells started to detach from the plastic 
surface. However, acquisition of the hepato-
cyte-specific morphology remained absent.  
Hepatic functionality of the cell line was 
tested using different techniques. First, the 
expression of multiple liver-specific markers 
was examined by RT-qPCR and WB anal-
yses (Figures 6 and 7). It was found that the 
mRNA levels of most liver-enriched tran-
scription factors, in casu hepatocyte nuclear 
factor (HNF)1α, HNF4α, HNF3β and 
CCAAT/enhancer binding protein α 
(C/EBPα), as well as liver-specific proteins, 
namely ALB, A1AT and alpha-fetoprotein 
(AFP) were low in IHH-ET cells. Upon dif-
ferentiation, mRNA quantities of A1AT, 
HNF1α and HNF4α became significantly in-
creased, but were still lower than the values 
observed in non-transduced primary hepato-
cytes. The same trend was observed at the 
protein level for HNF4α and A1AT, but not 
for HNF1α. The mRNA levels of the metab-
olizing enzyme cytochrome P450 monooxy-
genase (CYP) 3A4 and its fetal counterpart 
CYP3A7, the uptake transporter sodium-
dependent taurocholate cotransporting poly-
peptide (NTCP) and the efflux transporters 
multidrug resistance-associated protein 
(MRP) 2 and bile salt export pump (BSEP), 
were also downregulated in IHH-ET cells. 
Only NTCP and BSEP mRNA quantities 
were elevated after differentiation. However, 
the levels reached were still very low com-
pared to those observed in non-transduced 
primary hepatocytes. Both IHH-ET and dif-
ferentiated IHH-ET (DIHH-ET) cells did not 
longer express the uptake transporter organic 
anion transporting polypeptide 1B1. In con-
trast, MRP1, which is barely expressed in 
adult human hepatocytes (Ct-value=33), was 
clearly present in the established cell line. 
Similar changes were noticed for the mature 
hepatocyte marker glucose-6-phosphate de-
hydrogenase (G6PD). When analyzing the 
mRNA expression of CYP1A2, very low ex-
pression levels were detected in the non-
transduced human hepatocytes (Ct-
value=33). With regard to cytokeratins 
(CKs), IHH-ET cells displayed an apparent 
decrease in CK8 and CK18 mRNA abun-
dance. However, for both CKs, an increase 
in mRNA amounts was observed in the 
DIHH-ET cells, which was also visible for 
CK18 at the protein level. Furthermore, 
IHH-ET cells tended to express high mRNA 
and protein amounts of CK7 and CK19, 
which are cholangiocyte markers found at 
insignificant mRNA (Ct-value=34) and 
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Figure 3: mRNA and protein expression levels of the immortalization genes in the cell line 
The cell line was grown in growth cell culture medium and sampling was performed upon 90 % conflu-
ence. Results represent IHH-ET cells of 3 different cultivations (n=3, N=1). The original primary human 
hepatocytes were included in the analyses as a reference (n=1, N=1).  
A) Samples were subjected to RT-qPCR analysis, using B2M, UBC, ACTB and HPRT1 as a combi-
nation of reference genes for normalization. Each sample was analyzed in duplicate. The results were 
processed with the qbase+ software and mRNA expression levels were normalized against the geo-
metric mean of the selected reference genes and scaled to the values of original primary human 
hepatocytes. Results are expressed as mean + standard deviation in logarithmic scale.  
B) Samples (25 µg protein) were subjected to WB analysis. Primary antibodies against cyclin D1, 
CDK4 or TERT were used followed by appropriate secondary antibodies. Ponceau S staining is used 
as a control for equal loading and HEK293t cells (10 µg protein) transduced with the respective immor-
talization gene as positive control. Samples composed of RIPA lysis buffer and sample buffer without 
the addition of any cell lysate are used as negative control. (ACTB, beta actin; B2M, beta-2 micro-
globulin; CDK4, cyclin dependent kinase 4; HH, human hepatocytes; HPRT1, hypoxanthine ribosyl-
transferase 1; IHH-ET, immortalized human hepatocytes; mRNA, messenger ribonucleic acid; NC, 
negative control; PC, positive control; RIPA, radio-immunoprecipitation assay; RT-qPCR, real time 
quantitative polymerase chain reaction; TERT, telomerase reverse transcriptase; UBC, ubiquitin C; 
WB, western blot) 
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Figure 4: Flow cytometry analysis of immortalization gene expression profiles 
The cell line was grown in growth cell culture medium and cells were trypsinized at 90 % confluence, 
fixed and labeled with fluorescence labeled primary antibodies. Results represent IHH-ET cells from 
one cultivation (n=1, N=1).  
(A) The cell line was selected and tested for CDK4-FITC, cyclin D1-R-PE, TERT-PerCP-Cy5.5 and 
Hoechst-positive events. The number of positive events in the selected population is indicated as per-
centage on the graph.  
(B) The combined expression of cyclin D1 and TERT in the selected cell line population is determined. 
The right upper side represents the dual cyclin D1 and TERT-positive events in the selected cell line 
population. The number of events is indicated as a percentage in every quarter of the graph. (CDK4, 
cyclin dependent kinase 4; Cy, cyanine; FITC, fluorescein; FSC, forward scatter; IHH-ET cells, immor-
talized human hepatocytes; PerCP, Peridinin chlorophyll protein complex; R-PE, R-phycoerythrin; 
TERT, telomerase reverse transcriptase; SSC, side scatter) 
 
 
Figure 5: Morphologic appearance of the cell line 
The cell line was cultured in growth cell culture medium until nearly confluent (IHH-ET cells) or 2 more 
weeks in differentiation cell culture medium (DIHH-ET cells). Images were taken at 100x magnifica-
tion. The figure is representative for IHH-ET and DIHH-ET cells from 3 different cultivations (n=3). A 
figure of primary human hepatocytes is included for comparison. (DIHH-ET, differentiated immortal-
ized human hepatocytes; IHH-ET, immortalized human hepatocytes) 
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Figure 6: mRNA expression levels of liver-specific markers in the cell line 
The cell line was cultured in growth cell culture medium until nearly confluent (IHH-ET cells) or 2 more 
weeks in differentiation cell culture medium (DIHH-ET cells) before samples were taken. Samples 
were subjected to RT-qPCR analysis, using B2M, UBC, ACTB and HPRT1 as a combination of refer-
ence genes for normalization. Samples were analyzed in duplicate. The results were processed with 
the qbase+ software and mRNA expression levels were normalized against the geometric mean of the 
selected reference genes and scaled to the original primary human hepatocytes. Results are ex-
pressed as mean + standard deviation in logarithmic scale and represent IHH-ET and DIHH-ET cells 
of 3 different cultivations (n=3, N=1). Statistical analysis was performed using a 2-tailed unpaired t-test 
with significance p < 0.05 (*). (A1AT, alpha-1-antitrypsin; ACTB, beta actin; AFP, alpha-fetoprotein; 
ALB, albumin; B2M, beta-2 microglobulin; BSEP, bile salt export pump; C/EBP, CCAAT/enhancer 
binding protein; CK, cytokeratin; CYP, cytochrome P450; DIHH-ET, differentiated IHH-ET; G6PD, glu-
cose-6-phosphatase dehydrogenase; GGT1, gamma-glutamyltransferase 1; HNF, hepatocyte nuclear 
factor; HPRT1, hypoxanthine ribosyltransferase 1; IHH-ET, immortalized human hepatocytes; mRNA, 
messenger ribonucleic acid; MRP, multidrug resistance-associated protein; NTCP, sodium-dependent 
taurocholate cotransporting polypeptide; RT-qPCR, real time quantitative polymerase chain reaction; 
UBC, ubiquitin C) 
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Figure 7: Protein expression levels of liver-
specific markers in the cell line 
The cell line was cultured in growth cell culture 
medium until nearly confluent (IHH-ET cells) or 2 
more weeks in differentiation cell culture medium 
(DIHH-ET cells) before samples were taken. 
Samples (25 µg protein) were subjected to WB 
analysis. Primary antibodies directed against re-
spective antigens were used followed by an ap-
propriate secondary antibody. Ponceau S stain-
ing is used as a control for equal loading. Results 
represent cells of 3 different cultivations (n=3, 
N=1). Samples composed of RIPA lysis buffer 
and sample buffer without the addition of any cell 
lysate are used as negative controls. (A1AT, al-
pha-1-antitrypsin; CK, cytokeratin; DIHH-ET, dif-
ferentiated IHH-ET; HH, human hepatocytes; 
HNF, hepatocyte nuclear factor; IHH-ET, immor-
talized human hepatocytes; NC, negative control: 
WB, Western blot) 
 
protein levels in the non-transduced human 
hepatocytes. In contrast to other CKs, the 
mRNA levels of CK19 were decreased in 
DIHH-ET cells, which was equally visible at 
the protein level for DIHH-ET2 and DIHH-
ET3 cells. Another biliary marker, gamma-
glutamyltransferase 1 (GGT1) was detected 
in the non-transduced human hepatocytes 
(Ct-value=24) and exhibited an opposite 
regulation to CK19 in IHH-ET and DIHH-
ET cells.  
In accordance with the RT-qPCR data, 
the amount of A1AT and ALB secreted per 
hour in the culture medium for the IHH-ET 
cells was very low (25 ± 12 ng A1AT/mg 
protein) or even hardly measurable (8 10-4 
± 4 10-4 ng ALB/mg protein), but reached 
higher levels (207 ± 56 ng A1AT/mg pro-
tein; 79 ± 41 ng ALB/mg protein) in the 
DIHH-ET cells (Figure 8).  
With respect to the capacity for glycogen 
storage, a difference can be observed be-
tween the IHH-ET and DIHH-ET cells. Only 
differentiated cells displayed a clear PAS-
staining, which visibly decreased after α-
amylase treatment (Figure 9). 
 
DISCUSSION 
The aim of this study was to develop a 
human hepatic cell line using an established 
immortalization strategy (Shiomi et al., 
2011), based on the combined overexpres-
sion of TERT and the cell cycle regulators, 
cyclin D1 and CDK4R24C, rather than viral 
oncogenes to overcome the early growth ar-
rest of adult human hepatocytes and immor-
talize the cells. When adult human hepato-
cytes were simultaneously transduced with 
the 3 immortalization genes, colony for-
mation became visible in the culture system 
and a cell line was established. The prolifer-
ating cells possessed a PDT of approximate-
ly 30 hours, which is in line with those of 
other immortalized human hepatic cell lines 
(Pfeifer et al., 1993; Nguyen et al., 2005). 
However, as hepatocyte differentiation and 
proliferation are typically mutually exclusive 
in vitro, cell growth was associated with de-
terioration of the differentiated morphology 
and functional phenotype, a phenomenon al-
ready described by others (Kim et al., 2000; 
Chamuleau et al., 2005). It was found that 
IHH-ET cells display downregulated expres-
sion of most hepatocytic markers and liver-
enriched transcription factors at the tran-
scriptional and/or translational level. In con-
trast, mRNA quantities of MRP1 were ele-
vated. The expression of this efflux drug 
transporter has been linked to the prolifera-
tion rate of hepatocytes, with increased 
mRNA and protein levels in proliferating 
hepatocytes (Roelofsen et al., 1997, 1999; 
Schippers et al., 1997). Upregulation of the 
mRNA production was also observed for 
G6PD, a mature hepatocyte marker. Its de-
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Figure 8: Secretion of liver-specific proteins of the cell line 
Cells were grown in 6-well plates and secretion of ALB and A1AT in cell culture medium of 3 different 
wells (N=3) was measured by means of ELISA. Results are expressed as mean + standard deviation 
of 3 different cultivations (n=3).Statistical analysis was performed using a 2-tailed unpaired t-test with 
significance p < 0.05 (*). (A1AT, alpha-1-antitrypsin; ALB, albumin; DIHH-ET cells, differentiated IHH-
ET cells; ELISA, enzyme-linked immunosorbent assay; IHH-ET cells, immortalized human hepato-
cytes) 
 
Figure 9: Glycogen storage in the cell line 
Cells were grown in 6-well plates and after cultivation a PAS-staining was performed. Diastase treat-
ment served as negative control with IHH-ET and DIHH-ET cells incubated for 1.5 and 7.5 minutes, 
respectively. Images were taken at 200x magnification. Images are representative for cells of 3 differ-
ent cultivations (n=3). (DIHH-ET, differentiated IHH-ET; IHH-ET, immortalized human hepatocytes, 
PAS, Periodic acid Schiff) 
 
 
viant expression pattern in proliferating 
hepatocytes remains elusive, yet enhanced 
activity of this marker has been associated 
with cellular proliferation in NIH 3T3 cells 
(Kuo and Tang, 1999). Besides the observed 
changes for hepatocytic markers, the IHH-
ET cells expressed the cholangiocyte mark-
ers CK7 and CK19, which may point to 
hepatocyte dedifferentiation (Blaheta et al., 
1998; Deurholt et al., 2009). The appearance 
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of a mixed CK phenotype in immortalized 
hepatic cell lines has previously been de-
scribed (Smalley et al., 2001; Clayton et al., 
2005). The concomitant increased expression 
of the hepatic progenitor cell marker THY1 
(data not shown), actually suggests that the 
IHH-ET cells possess a rather bipotential he-
patic progenitor-like phenotype (Iacob et al., 
2011).  
Over the years, several strategies to 
counteract the dedifferentiation of hepatic 
cell lines have been proposed. The use of re-
versible immortalization techniques has 
proven useful to some extent and might be 
interesting to introduce in future cell lines 
(Kobayashi et al., 2000; Chamuleau et al., 
2005; Nguyen et al., 2005; Totsugawa et al., 
2007). Furthermore, increasing attention 
should be paid to culture systems that sup-
port and/or promote the differentiation status 
of immortalized hepatocytes, such as 3D or 
co-culture systems (Werner et al., 1999, 
2000; Watanabe et al., 2003; Chamuleau et 
al., 2005; Deurholt et al., 2009; Zhao et al., 
2012). In this study, cellular overgrowth oc-
curred when IHH-ET cells were cultivated 
for 2 more weeks in serum-free culture me-
dium. While no improvement was observed 
morphologically, the cell line displayed an 
enhanced hepatic phenotype. Indeed, in-
creased expression of several hepatocytic 
markers, including A1AT, CK8, CK18, 
NTCP and BSEP and the liver-enriched tran-
scription factors, HNF1α and HNF4α was 
detected at the transcriptional and/or transla-
tional level. Moreover, DIHH-ET cells se-
creted higher levels of the liver-specific pro-
teins ALB and A1AT and displayed glyco-
gen deposition.  
In conclusion, the innovative immortali-
zation strategy applied to primary human 
hepatocytes in this study generates a novel 
hepatic cell line that seems to retain some 
key hepatic characteristics when cultured 
under appropriate conditions.  
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